Pharmaceuticals

China Pharma

China Pharma released FY2025 Q3 earnings on November 12 (EST), actual revenue USD 756.22K, actual EPS USD -0.1681

China Pharma released FY2025 9 Months earnings on November 12, 2025 (EST), actual revenue USD 2.918M, actual EPS USD -0.5709

China Pharma released FY2025 Semi-Annual earnings on August 14 (EST), actual revenue USD 2.162 M, actual EPS USD -0.4028

China Pharma released FY2025 Q2 earnings on August 14 (EST), actual revenue USD 1.026 M, actual EPS USD -0.1619

China Pharma released FY2025 Q1 earnings on May 14 (EST), actual revenue USD 1.136 M, actual EPS USD -0.2408

China Pharma released FY2024 Q4 earnings on March 31 (EST), actual revenue USD 1.134 M, actual EPS USD -0.5306

China Pharma released FY2024 Annual Earnings on March 31 (EST), with actual revenue of USD 4.529 M and EPS of USD -2.7121

China Pharma released FY2024 Q3 earnings on November 13 (EST), actual revenue USD 1.1 M, actual EPS USD -0.6459

China Pharma released FY2024 9 Months Earnings on November 13 (EST), actual revenue USD 3.395 M, actual EPS USD -2.2549

China Pharma released FY2024 Semi-Annual Earnings on August 14 (EST), with actual revenue of USD 2.295 M and EPS of USD -1.6255

China Pharma released FY2024 Q2 earnings on August 14 (EST), actual revenue USD 924.94 K, actual EPS USD -0.8919

China Pharma released FY2024 Q1 earnings on May 15 (EST), actual revenue USD 1.37 M, actual EPS USD -0.717

China Pharma released FY2023 Annual Earnings on April 1, 2024 (EST), with actual revenue of USD 7.011 M and EPS of USD -9.0993

China Pharma released FY2023 Q4 earnings on April 1, 2024 (EST), with actual revenue of USD 2.15 M and EPS of USD -1.6924

China Pharma released FY2023 9 Months Earnings on November 13 (EST), with actual revenue of USD 4.862 M and EPS of USD -9.3967

China Pharma released FY2023 Q3 earnings on November 13 (EST), actual revenue USD 1.803 M, actual EPS USD -2.9418

China Pharma released FY2023 Semi-Annual Earnings on August 14 (EST), with actual revenue of USD 3.058 M and EPS of USD -6.4667

China Pharma released FY2023 Q2 earnings on August 14, 2023 (EST), with actual revenue of USD 1.098 M and EPS of USD -3.509

China Pharma released FY2023 Q1 earnings on May 12 (EST), actual revenue USD 1.96 M, actual EPS USD -2.9458

China Pharma released FY2022 Q4 earnings on March 30, 2023 (EST), with actual revenue of USD 2.921 M and EPS of USD -9.8211

The Gabelli Equity Trust Inc.

Cyclerion Therapeutics

PMGC

Axe Compute

Mega Fortune

FLAG SHIP ACQUISITION CORPORATION COM USD0.001 (SUB/RIGHT 31/03/2026)

System1

RYTHM

U Power

RenX Enterprises

Eli Lilly

ROCHE HOLDINGS AG

Roche

AstraZeneca

NOVARTIS AG

Novo Nordisk AS

Chugai Pharmaceutical

UCB S.A.

Otsuka Pharmaceutical

Daiichi Sankyo

Style Score

Growth Score

Revenue YoY

Net Profit YoY

Value Score

P/B Ratio

Dividend Ratio

Size Score

Market Cap Score

Market Cap

Revenue Score

Revenue

Multi Score

Profit Score

Profit Margin

Gross Margin

Total Assets YoY

Net Assets YoY

Cash Score

Cash Flow Margin

OCF YoY

Operating Score

Turnover

Debt Score

Gearing Ratio

Please note that a "Suspected value trap" is a stock that appears The stock looks financially sound and severely undervalued, but behind the low valuation is a long-term decline in business capacity or a serious financial crisis, or even the risk of bankruptcy in the short term.

Suspected value trap

China Pharma(CPHI.US)

China Pharma Stock Performance Chart